FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula (I) possessing an ability to inhibit cell proliferation and IL-2 production, their pharmaceutically acceptable salts, as well as to based pharmaceutical compositions. In general formula:
R1 represents hydrogen; each of R2, R3 and R4 independently represents: hydrogen; halogen; -(CH2)nOH; (C1-C6)alkyl optionally substituted by one or more halogens; (C1-C6)alkoxy; or -(CH2)nNHRa, wherein Ra represents: hydrogen; -C(O)-(CH2)n- (6-10-member aryl) wherein aryl is optionally substituted by one or more: halogen; -SCF3; (C1-C6)alkyl, said alkyl itself is optionally substituted by one or more halogens; or (C1-C6)alkoxy with said alkoxy itself being optionally substituted by one or more halogens; -C(O)-(C1-C6)alkyl; -C(O)-(CH2)n(C3-C10-cycloalkyl); -C(O)-(CH2)n-NRbRc, wherein each Rb and Rc independently represent: hydrogen; (C1-C6)alkyl; 6-10-member aryl optionally substituted by one or more: halogen; (C1-C6)alkyl; or (C1-C6)alkoxy optionally substituted by one or more halogens; -C(O)-(CH2)n-O-(C1-C6)alkyl; or -C(O)-(CH2)n-O-(CH2)n-(6-10-member aryl); or R2 and R3 together can form a 6-member ring; R5 represents hydrogen or (C1-C6)alkyl; R6 represents hydrogen; and n represents 0 or 1; provided at least one of R2, R3 and R4 is other than hydrogen.
EFFECT: preparing the compounds possessing an ability to inhibit cell proliferation and IL-2 production.
23 cl, 51 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 5-SUBSTITUTED QUINAZOLINONE, COMPOSITIONS CONTAINING THEM AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2617989C2 |
5-SUBSTITUTED QUINAZOLINONE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHODS FOR USING THEM | 2007 |
|
RU2463298C2 |
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
5-SUBSTITUTED ISOINDOLINE COMPOUNDS | 2007 |
|
RU2448101C2 |
ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
Authors
Dates
2013-02-27—Published
2008-09-25—Filed